Form 4 for HCA HCA Healthcare
Accepted 2023-02-01 00:00:00 ET · period of report 2023-01-30 · accession 0001209191-23-006044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-01 | 2023-02-01 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | F - Tax | $255.07 | -586 | 11.7K | -5% | -$149.5K |
| D | 2023-02-01 | 2023-01-31 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | M - OptEx | $69.58 | +1,250 | 12.3K | +11% | +$87.0K |
| D | 2023-02-01 | 2023-01-31 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | G - Gift | $0.00 | -341 | 11.0K | -3% | $0 |
| D | 2023-02-01 | 2023-01-31 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | M - OptEx | $0.00 | -1,250 | 2,510 | -33% | $0 |
| D | 2023-02-01 | 2023-01-30 | HCA | Whalen Kathleen M | SVP, Chief Ethics Off | A - Grant | $0.00 | +3,789 | 3,789 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-01 | F | D | 586 | $255.07 | 11,696 | D | — | — | |
| 2 | Common | Common Stock | 2023-01-31 | M | A | 1,250 | $69.58 | 12,282 | D | — | — | |
| 3 | Common | Common Stock | 2023-01-31 | G | D | 341 | $0.00 | 11,032 | D | — | — | |
| 4 | Derivative | Stock Appreciation Right | 2023-01-31 | M | D | 1,250 | $0.00 | 2,510 | D | $69.58 · — to 2026-01-29 | 1,250 Common Stock | (F2) The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017. |
| 5 | Derivative | Stock Appreciation Right | 2023-01-30 | A | A | 3,789 | $0.00 | 3,789 | D | $253.30 · 2024-01-30 to 2033-01-30 | 3,789 Common Stock | (F1) The stock appreciation rights vest in four equal annual installments beginning on January 30, 2024. |